Gastroenterology
Volume 136, Issue 5 , Pages 1495-1498 , May 2009

HuR and TTP: Two RNA Binding Proteins That Deliver Message From the 3′ End

  • Shrikant Anant

      Affiliations

    • Department of Medicine, Section of Digestive Diseases and Nutrition and Department of Cell Biology and OU Cancer Institute, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
    • Corresponding Author InformationReprint requests Address requests for reprints to: Shrikant Anant, PhD. fax: (405) 271-5450
    • ,
  • Courtney W. Houchen

      Affiliations

    • Department of Medicine, Section of Digestive Diseases and Nutrition and OU Cancer Institute, University of Oklahoma Health Sciences Center and VA Medical Center, Oklahoma City, Oklahoma

References 

  1. Samoha S, Arber N. Cyclooxygenase-2 inhibition prevents colorectal cancer: from the bench to the bed side. Oncology. 2005;69(suppl 1):33–37
  2. Le Tourneau C, Vidal L, Siu LL. Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents. Drug Resist Updat. 2008;11:99–109
  3. Erman M. Molecular mechanisms of signal transduction: epidermal growth factor receptor family, vascular endothelial growth factor family, Kit, platelet-derived growth factor receptor, Ras. J Buon. 2007;129(suppl 1):S83–S94
  4. Bren-Mattison Y, Meyer AM, Van Putten V, et al. Antitumorigenic effects of peroxisome proliferator-activated receptor-gamma in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-kappaB. Mol Pharmacol. 2008;73:709–717
  5. Konstantinopoulos PA, Vandoros GP, Sotiropoulou-Bonikou G, et al. NF-kappaB/PPAR gamma and/or AP-1/PPAR gamma ‘on/off' switches and induction of CBP in colon adenocarcinomas: correlation with COX-2 expression. Int J Colorectal Dis. 2007;22:57–68
  6. Araki Y, Okamura S, Hussain SP, et al. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Cancer Res. 2003;63:728–734
  7. Kawasaki T, Nosho K, Ohnishi M, et al. Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer. Neoplasia. 2007;9:569–577
  8. Schmedtje JF, Ji YS, Liu WL, et al. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem. 1997;272:601–608
  9. Xu Q, Ji YS, Schmedtje JF. Sp1 increases expression of cyclooxygenase-2 in hypoxic vascular endothelium (Implications for the mechanisms of aortic aneurysm and heart failure). J Biol Chem. 2000;275:24583–24859
  10. Khare S, Mustafi R, Cerda S, et al. Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: roles of Ras, p38, and CCAAT/enhancer-binding protein. Nutr Cancer. 2008;60:389–400
  11. Liu Q, Inoue H, Mahendran R. Transcriptional regulation of the COX-2 expression by nitric oxide in colon cancer cell lines. Oncol Rep. 2008;19:269–274
  12. Harper KA, Tyson-Capper AJ. Complexity of COX-2 gene regulation. Biochem Soc Trans. 2008;36:543–545
  13. Moore MJ, Proudfoot NJ. Pre-mRNA processing reaches back to transcription and ahead to translation. Cell. 2009;136:688–700
  14. Dixon DA. Dysregulated post-transcriptional control of COX-2 gene expression in cancer. Curr Pharm Des. 2004;10:635–646
  15. Barreau C, Paillard L, Osborne HB. AU-rich elements and associated factors: are there unifying principles?. Nucleic Acids Res. 2005;33:7138–7150
  16. Aguilera O, Munoz A, Esteller M, et al. Epigenetic alterations of the Wnt/beta-catenin pathway in human disease. Endocr Metab Immune Disord Drug Targets. 2007;7:13–21
  17. Cok SJ, Acton SJ, Morrison AR. The proximal region of the 3′-untranslated region of cyclooxygenase-2 is recognized by a multimeric protein complex containing HuR, TIA-1, TIAR, and the heterogeneous nuclear ribonucleoprotein U. J Biol Chem. 2003;278:36157–36162
  18. Cok SJ, Acton SJ, Sexton AE, et al. Identification of RNA-binding proteins in RAW 264.7 cells that recognize a lipopolysaccharide-responsive element in the 3-untranslated region of the murine cyclooxygenase-2 mRNA. J Biol Chem. 2004;279:8196–8205
  19. Dixon DA, Balch GC, Kedersha N, et al. Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1. J Exp Med. 2003;198:475–481
  20. Herranz M, Esteller M. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets. Meth Mol Biol. 2007;361:25–62
  21. Lin NY, Lin CT, Chang CJ. Modulation of immediate early gene expression by tristetraprolin in the differentiation of 3T3-L1 cells. Biochem Biophys Res Commun. 2008;365:69–74
  22. Lopez de Silanes I, Galban S, Martindale JL, et al. Identification and functional outcome of mRNAs associated with RNA-binding protein TIA-1. Mol Cell Biol. 2005;25:9520–9531
  23. Lopez de Silanes I, Quesada MP, Esteller M. Aberrant regulation of messenger RNA 3′-untranslated region in human cancer. Cell Oncol. 2007;29:1–17
  24. Sureban SM, Ramalingam S, Natarajan G, et al. Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe. Oncogene. 2008;27:4544–4556
  25. Nabors LB, Furneaux HM, King PH. HuR, a novel target of anti-Hu antibodies, is expressed in non-neural tissues. J Neuroimmunol. 1998;92:152–159
  26. Dixon DA, Tolley ND, King PH, et al. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest. 2001;108:1657–1665
  27. Young LE, Sanduja S, Bemis-Standoli K, et al. The mRNA Binding Proteins HuR and Tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis. Gastroenterology. 2009;136:1669–1679
  28. Carballo E, Lai WS, Blackshear PJ. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood. 2000;95:1891–1899
  29. Sawaoka H, Dixon DA, Oates JA, et al. Tristetraprolin binds to the 3′-untranslated region of cyclooxygenase-2 mRNA (A polyadenylation variant in a cancer cell line lacks the binding site). J Biol Chem. 2003;278:13928–13935
  30. Mukhopadhyay D, Houchen CW, Kennedy S, et al. Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol Cell. 2003;11:113–126
  31. Katsanou V, Papadaki O, Milatos S, et al. HuR as a negative posttranscriptional modulator in inflammation. Mol Cell. 2005;19:777–789
  32. Sureban SM, Murmu N, Rodriguez P, et al. Functional antagonism between RNA binding proteins HuR and CUGBP2 determines the fate of COX-2 mRNA translation. Gastroenterology. 2007;132:1055–1065

 Conflicts of interest The authors disclose no conflicts.

PII: S0016-5085(09)00446-6

doi: 10.1053/j.gastro.2009.03.024

Gastroenterology
Volume 136, Issue 5 , Pages 1495-1498 , May 2009

Article Tools

* Image Usage & Resolution